{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/810545508",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/489508344"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#810545508",
  "code": "EH70",
  "source": "http://id.who.int/icd/entity/810545508",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Non-melanin pigmentation due to drug"
      },
      "foundationReference": "http://id.who.int/icd/entity/1950677208",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/609177862/other"
    }
  ],
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/810545508/postcoordinationScale/specificAnatomy",
      "axisName": "http://id.who.int/icd/schema/specificAnatomy",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/223243926",
        "http://id.who.int/icd/release/11/2024-01/mms/947150833",
        "http://id.who.int/icd/release/11/2024-01/mms/1810600222"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/810545508/postcoordinationScale/associatedWith",
      "axisName": "http://id.who.int/icd/schema/associatedWith",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1583926619",
        "http://id.who.int/icd/release/11/2024-01/mms/1323892810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Pigmentary abnormalities of skin due to drug"
  },
  "definition": {
    "@language": "en",
    "@value": "Disturbances of skin colour due to an ingested or injected drug. These may result from a number of different mechanisms including the colour of the drug itself, disturbed melanisation of the skin or deposition of pigments by drug breakdown products."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Pigmentary abnormalities of skin due to drug"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "drug application site discolouration"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "discolouration of skin due to drug"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced hypermelanosis"
      },
      "foundationReference": "http://id.who.int/icd/entity/1818632208"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced hypomelanosis"
      },
      "foundationReference": "http://id.who.int/icd/entity/1913292067"
    },
    {
      "label": {
        "@language": "en",
        "@value": "medicament-induced hypomelanosis"
      },
      "foundationReference": "http://id.who.int/icd/entity/1913292067"
    }
  ]
}